In particular, DCM/ACM with LMNA mutations, which represent 5–10% of all DCM patients, are associated with early atrial and ventricular arrhythmias, premature conduction disease, a high risk of SCD, and progression to end-stage heart failure [73,74]. Here, LMNA is linked to familial dilated cardiomyopathy.